Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
8.23
+0.23 (2.88%)
Apr 22, 2025, 4:00 PM EDT - Market closed
Immunome Market Cap
Immunome has a market cap or net worth of $715.60 million as of April 22, 2025. Its market cap has decreased by -40.83% in one year.
Market Cap
715.60M
Enterprise Value
489.22M
1-Year Change
-40.83%
Ranking
Category
Stock Price
$8.23
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $715.60M, an increase of 542.43%. That is a compound annual growth rate of 50.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2025 | 695.61M | 4.94% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 745.71B |
| UnitedHealth Group | 397.05B |
| Johnson & Johnson | 380.51B |
| AbbVie | 304.65B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 228.43B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |